Akero Therapeutics Inc. (AKRO)
Akero Therapeutics Max Pain By Strike
AKRO trades at $44.72, 10.6% below the near-term max pain of $50 expiring Sep 19, 2025 (11 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is rising across expirations ($30-$50), reflecting growing call interest at higher strikes. Key magnetic zone at 45 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Akero Therapeutics Max Pain By Expiry
Max pain for AKRO shows an upward trend from 30 to 50, suggesting bullish positioning in longer-dated options. The 45% spread signals divergent expectations across timeframes. Most levels above 44.72 could support dips. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 50 | 5.28 (11.81%) |
| Oct 17, 2025 | 45 | 0.28 (0.63%) |
| Nov 21, 2025 | 50 | 5.28 (11.81%) |
| Jan 16, 2026 | 30 | -14.72 (-32.92%) |
| Feb 20, 2026 | 45 | 0.28 (0.63%) |